|
Home | Agenda | Speakers | Keynotes | Pre-Conference | Tracks | Venue | Resources | Networking | REGISTER | BROCHURE | Sponsors | Exhibitors | Partners |
Keynotes
| Keynote Sessions |
Two Part Keynote: Can the Current R&D Business Model Survive? Part 1: Learning from the Golden Age of Pharma:In part one of this two part discussion, Dr. P Roy Vagelos looks back to the “Golden Age” and highlights his lessons learned and the keys to success during his 10 year tenure as the CEO of Merck, as well as how these experiences can translate across the rest of…(download brochure for full session description)
Part II: Strategies for Innovation and Growth in the Changing Pharma Environment How much more efficient must pharma and biotech become tosurvive in the market of the future? In order to sustain R&D investment at traditional levels, the industry must evolve- to break down the current monolithic R&D structures and fundamentally restructure the… (download brochure for full session description)    Panelists:
|
| Critical Path Initiative Update Although investment in R&D has increased, trial success rates are actually declining. The industry continues to use the same evaluation tools and infrastructure of the last century to develop this century’s medical advances. To advance the critical path, the industry must modernize- modernize science into the process, into the regulation, and into the manufacturing, and modernize the current structure of working with the FDA to…(download brochure for full session description)
|
| Leaders Unite to Re-Think the Conduct of U.S. Based Clinical Trials: Clinical Trials Transformation Initiative Executive Committee Update To combat the growing consensus that clinical trials in the U.S. are becoming too costly and inefficient, leading figures in government, academia, industry, and patient advocacy are uniting to modernize the way trials are conducted in the United States. This public-private partnership has the potential to jump-start much needed innovation in the conduct, analysis and…(download brochure for full session description)   Panelists:
|
| Are M&A’s the New R&D? How Pharma/Biotech R&D Collaboration Is Driving Pipeline Innovation With Big Pharma facing challenges of dwindling pipelines, and smaller biotechs often lacking the resources to invest in large-scale clinical trials, the benefits of collaboration are clear. In the face of growing competition and bottom line profits at stake, Pharma/Biotech partnering has emerged as …(download brochure for full session description) Panelists:
|
Creating a Mission-Driven Organization: Communication, Change Management & Keeping the Patient at the Heart of the Business The Children’s Hospital of Philadelphia (CHOP) is the nation’s first and largest children’s hospital, with over 17,000 patient admitted annually. Dr. Altshculer will outline how he creating a mission-driven organization that united all employees around a uniform set of goals and …(download brochure for full session description)
|
| The Keys to Clinical Operations Success: Optimizing the Process by Focusing on The People First The hot topic in clinical operations always comes back to two factors: efficiency and productivity. While much focus has been given to ‘changing the R&D paradigm’ to achieve optimization, the topic of handling the ‘people side’ of operational success is …(download brochure for full session description)   Panelists:
|